Thomas Andrew Rowland

CIK: 0001507496

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (23.1%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (23.1%)

Compensation grants

Other (G, F, J, C, D, …)7 (53.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ANIP

ANI PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (13 total)

ANIP
ANI PHARMACEUTICALS INC
May 12, 2026
Sale(S)
Direct
459 shares at avg. $79.21$36K
ANIP
ANI PHARMACEUTICALS INC
Mar 11, 2026
Sale(S)
Direct
4.8K shares at avg. $74.91$357K
ANIP
ANI PHARMACEUTICALS INC
Feb 28, 2026
Tax Payment(F)
Direct
628 shares at avg. $73.90$46K
ANIP
ANI PHARMACEUTICALS INC
Feb 26, 2026
Award(A)
Direct
6K shares at avg. $77.15$465K
ANIP
ANI PHARMACEUTICALS INC
Feb 14, 2026
Tax Payment(F)
Direct
485 shares at avg. $77.36$38K
ANIP
ANI PHARMACEUTICALS INC
Feb 12, 2026
Tax Payment(F)
Direct
566 shares at avg. $76.70$43K
ANIP
ANI PHARMACEUTICALS INC
Feb 11, 2026
Tax Payment(F)
Direct
1.8K shares at avg. $76.25$134K
ANIP
ANI PHARMACEUTICALS INC
Aug 12, 2025
Sale(S)
Direct
5K shares at avg. $85.71$426K
ANIP
ANI PHARMACEUTICALS INC
Feb 28, 2025
Tax Payment(F)
Direct
627 shares at avg. $61.89$39K
ANIP
ANI PHARMACEUTICALS INC
Feb 14, 2025
Tax Payment(F)
Direct
582 shares at avg. $58.92$34K
ANIP
ANI PHARMACEUTICALS INC
Feb 12, 2025
Award(A)
Direct
7.8K shares-
ANIP
ANI PHARMACEUTICALS INC
Feb 12, 2025
Award(A)
Direct
5.2K shares-
ANIP
ANI PHARMACEUTICALS INC
Nov 15, 2024
Tax Payment(F)
Direct
867 shares at avg. $56.58$49K

		Type	Shares	Price		Ownership
May 12, 2026	ANIP ANI PHARMACEUTICALS INC	Sale(S)	459	$79.21	$36,357	Direct
Mar 11, 2026	ANIP ANI PHARMACEUTICALS INC	Sale(S)	4,772	$74.91	$357,471	Direct
Feb 28, 2026	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	628	$73.90	$46,409	Direct
Feb 26, 2026	ANIP ANI PHARMACEUTICALS INC	Award(A)	6,021	$77.15	$464,520	Direct
Feb 14, 2026	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	485	$77.36	$37,520	Direct
Feb 12, 2026	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	566	$76.70	$43,412	Direct
Feb 11, 2026	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	1,762	$76.25	$134,353	Direct
Aug 12, 2025	ANIP ANI PHARMACEUTICALS INC	Sale(S)	4,975	$85.71	$426,407	Direct
Feb 28, 2025	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	627	$61.89	$38,805	Direct
Feb 14, 2025	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	582	$58.92	$34,291	Direct
Feb 12, 2025	ANIP ANI PHARMACEUTICALS INC	Award(A)	7,834	-	-	Direct
Feb 12, 2025	ANIP ANI PHARMACEUTICALS INC	Award(A)	5,222	-	-	Direct
Nov 15, 2024	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	867	$56.58	$49,055	Direct

1-13 of 13 transactions

About Rowland Thomas Andrew

Rowland Thomas Andrew (SEC CIK 0001507496) files insider reports with the SEC as SVP, HEAD - ESTABLISHED BRANDS of ANI PHARMACEUTICALS INC (ANIP).

Signal8 holds 9 ownership filings by Rowland Thomas Andrew, all Form 4s, filed between Nov 18, 2024 and May 13, 2026. Those filings report 13 transactions, from Nov 15, 2024 to May 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Rowland Thomas Andrew's filings is in BAUDETTE, MN.

Recent filings by Rowland Thomas Andrew

May 12, 2026: Open-market sale of ANIP shares (Form 4, code S).
Mar 11, 2026: Open-market sale of ANIP shares (Form 4, code S).
Feb 28, 2026: Tax withholding of ANIP shares (Form 4, code F).
Feb 26, 2026: Grant or award of ANIP shares (Form 4, code A).
Feb 14, 2026: Tax withholding of ANIP shares (Form 4, code F).

Other insiders filing for ANI PHARMACEUTICALS INC (ANIP)

CAREY STEPHEN P., SVP & CFO
Lalwani Nikhil, PRESIDENT & CEO
Cook Meredith, SR. VP, GENERAL COUNSEL & SEC.
Thoma Jeanne, Director
Gosebruch Henry O, Director
Gutwerg Ori, SVP, GENERICS

How to read Form 4 transaction codes